Mesothelioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Conditions:   Cutaneous Melanoma;   Non-small Cell Lung Cancer;   Colorectal Neoplasms;   Pancreatic Neoplasms;   Mesothelioma Intervention:   Drug: SGN-BB228 Sponsor:   Seagen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 7, 2022 Category: Research Source Type: clinical trials

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Conditions:   Ovarian Cancer;   Cholangiocarcinoma Recurrent;   Mesothelioma, Malignant Intervention:   Biological: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR Sponsor:   Verismo Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2022 Category: Research Source Type: clinical trials